miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance

miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance

Multiple myeloma (MM) produces clonal plasma cells and aberrant monoclonal antibody accumulation in patients’ bone marrow (BM). Around 1% of all cancers and 13% of hematological malignancies are caused by MM, making it one of the most common types of cancer. Diagnostic and therapeutic methods for ma...

Full description

Bibliographic Details
Main Authors: Ali Tavakoli Pirzaman MD, Pouyan Ebrahimi MD, Amir Hossein Hasanpour MD, Mahdi Shakeri MD, Bahareh Babajani MS, Zahra Pourali Ganji MS, Hedye Babaei MD, Amirhossein Rahmati MS, Rezvan Hosseinzadeh MD, Shahrbanoo Doostmohamadian MS, Sohrab Kazemi PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338231202391

Internet

https://doi.org/10.1177/15330338231202391

Similar Items